Insulin resistance

Arab Journal of Gastroenterology

Volumn 11, Issue 2, 2010, Pages 66-69

  El Zayadi, Abdel Rahman ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

HEPATITIS C; HUMAN; INSULIN RESISTANCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC SYNDROME X; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STEATOSIS;

EID: 77955274247     PISSN: 16871979     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajg.2010.04.010     Document Type: Review

References (41)

1. Ferrannini E., Natali A., Capaldo B., Lehtovirta M., Jacob S., Yki-Jarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European group for the study of insulin resistance (EGIR). Hypertension 1997, 30(5):1144-1149.
2. Facchini F.S., Hua N., Abbasi F., Reaven G.M. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001, 86(8):3574-3578.
3. Yip J., Facchini F.S., Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998, 83(8):2773-2776.
4. Harrison S.A. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. Clin Gastroenterol Hepatol 2008, 6(8):864-876.
5. Knobler H., Zhornicky T., Sandler A., Haran N., Ashur Y., Schattner A. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol 2003, 98(12):2751-2756.
6. Hunter S.J., Garvey W.T. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med 1998, 105(4):331-345.
7. Couillard C., Bergeron N., Prud'homme D., Bergeron J., Tremblay A., Bouchard C., et al. Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscl Thromb Vasc Biol 1999, 19(10):2448-2455.
8. Knobler H., Schattner A. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad. QJM 2005, 98(1):1-6.
9. Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Tsukamoto K., Kimura S., et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004, 126(3):840-848.
10. Kawaguchi T., Yoshida T., Harada M., Hisamoto T., Nagao Y., Ide T., et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004, 165(5):1499-1508.
11. Lager I., Attvall S., Eriksson B.M., von S.H., Smith U. Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors. Diabetologia 1986, 29(7):409-416.
12. Conn V.S., Hafdahl A.R., Mehr D.R., LeMaster J.W., Brown S.A., Nielsen P.J. Metabolic effects of interventions to increase exercise in adults with type 2 diabetes. Diabetologia 2007, 50(5):913-921.
13. Cartee G.D., Young D.A., Sleeper M.D., Zierath J., Wallberg-Henriksson H., Holloszy J.O. Prolonged increase in insulin-stimulated glucose transport in muscle after exercise. Am J Physiol 1989, 256(4 Pt 1):E494-E499.
14. Del P.S., Leonetti F., Simonson D.C., Sheehan P., Matsuda M., DeFronzo R.A. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994, 37(10):1025-1035.
15. Taylor G.W., Burt B.A., Becker M.P., Genco R.J., Shlossman M., Knowler W.C., et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996, 67(Suppl. 10):1085-1093.
16. Taylor G.W. The effects of periodontal treatment on diabetes. J Am Dent Assoc 2003, 134(Spec. No.):41S-48S.
17. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365(9468):1415-1428.
18. Avramoglu R.K., Basciano H., Adeli K. Lipid and lipoprotein dysregulation in insulin resistant states. Clin Chim Acta 2006, 368(1-2):1-19.
19. Mikhail N. The metabolic syndrome: insulin resistance. Curr Hypertens Rep 2009, 11(2):156-158.
20. Rabe K., Lehrke M., Parhofer K.G., Broedl U.C. Adipokines and insulin resistance. Mol Med 2008, 14(11-12):741-751.
21. Ouchi N., Shibata R., Walsh K. Targeting adiponectin for cardioprotection. Expert Opin Ther Targets 2006, 10(4):573-581.
22. Tsatsanis C., Zacharioudaki V., Androulidaki A., Dermitzaki E., Charalampopoulos I., Minas V., et al. Adiponectin induces TNF-alpha and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem Biophys Res Commun 2005, 335(4):1254-1263.
23. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7(8):947-953.
24. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001, 50(9):2094-2099.
25. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89(6):2548-2556.
26. Valtuena S., Numeroso F., Ardigo D., Pedrazzoni M., Franzini L., Piatti P.M., et al. Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levels. Eur J Endocrinol 2005, 153(2):283-290.
27. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271(5249):665-668.
28. De G.A., Pazienza V., Pugnale P., Bruttin F., Rubbia-Brandt L., Juge-Aubry C.E., et al. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection. Aliment Pharmacol Therap 2006, 23(1):107-114.
29. Cavallo-Perin P., Cassader M., Bozzo C., Bruno A., Nuccio P., Dall'omo A.M., et al. Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect. J Clin Invest 1985, 75(5):1659-1665.
30. Cavallo-Perin P., Bruno A., Nuccio P., Goria M., Pagano G., Lenti G. Feedback inhibition of insulin secretion is altered in cirrhosis. J Clin Endocrinol Metab 1986, 63(4):1023-1027.
31. Nygren A., Adner N., Sundblad L., Wiechel K.L. Insulin uptake by the human alcoholic cirrhotic liver. Metabolism 1985, 34(1):48-52.
32. El-Zayadi A.R., Selim O.E., Hamdy H., Dabbous H., Ahdy A., Moniem S.A. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol 1998, 19(4):141-144.
33. Zekry A., McHutchison J.G., Diehl A.M. Insulin resistance and steatosis in hepatitis C virus infection. Gut 2005, 54(7):903-906.
34. Chitturi S., Abeygunasekera S., Farrell G.C., Holmes-Walker J., Hui J.M., Fung C., et al. NASH and insulin resistance. Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35(2):373-379.
35. Marchesini G., Brizi M., Morselli-Labate A.M., Bianchi G., Bugianesi E., McCullough A.J., et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999, 107(5):450-455.
36. Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002, 35(2):367-372.
37. Pazienza V., Clement S., Pugnale P., Conzelman S., Foti M., Mangia A., et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 2007, 45(5):1164-1171.
38. Willner I.R., Waters B., Patil S.R., Reuben A., Morelli J., Riely C.A. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 2001, 96(10):2957-2961.
39. Cave M., Deaciuc I., Mendez C., Song Z., Joshi-Barve S., Barve S., et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007, 18(3):184-195.
40. Romero-Gomez M., Del M.V., Andrade R.J., Salmeron J., Diago M., Fernandez-Rodriguez C.M., et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005, 128(3):636-641.
41. Kaserer K., Fiedler R., Steindl P., Muller C.H., Wrba F., Ferenci P. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology 1998, 32(5):454-461.